文献速递心外重症与机械循环支持

不良事件对左心室辅助装置植入后健康相关生活质量的影响:一项STS INTERMACS分析

Impact of adverse events on health-related quality of life after left ventricular assist device implantation: An STS INTERMACS analysis.
PubMed 文献 · J Heart Lung Transplant · 2023-04-09

该研究基于INTERMACS注册数据,纳入2012至2019年首次植入耐久性左心室辅助装置(LVAD)的患者,采用多变量广义线性模型评估术前变量和术后不良事件(AE)对6个月和3年时健康相关生活质量(HRQOL,采用EQ-5D视觉模拟量表VAS和KCCQ-12评估)的影响。结果显示,术后AE对HRQOL有较大的负向效应,而术前变量(包括基线VAS)效应量较小;近期卒中、呼吸衰竭和肾功能不全对6个月HRQOL负向影响最大,近期肾功能不全、呼吸衰竭和感染对3年HRQOL负向影响最大。

要点

  • LVAD植入后6个月和3年VAS与KCCQ均较术前改善。
  • 术后不良事件对HRQOL有较大负向效应,术前变量效应量较小。
  • 6个月时近期卒中、呼吸衰竭、肾功能不全负向影响最大;3年时近期肾功能不全、呼吸衰竭、感染负向影响最大。

核心结论

  • LVAD植入后不良事件在早期和晚期随访中对HRQOL均有较大负向影响。
  • 理解不良事件对HRQOL的影响可能有助于LVAD适应证的共同决策。
  • 持续努力减少LVAD术后不良事件是必要的,以在生存之外改善HRQOL。

研究设计与样本

  • 研究识别了2012至2019年间INTERMACS注册中首次植入耐久性LVAD的患者。
  • 采用广义线性模型的多变量建模评估基线特征和术后不良事件对6个月和3年时EQ-5D VAS和KCCQ-12评估的HRQOL的影响。

主要发现

  • 共22,230例患者,其中9,888例在6个月时有VAS报告、10,552例有KCCQ报告;2,170例在3年时有VAS报告、2,355例有KCCQ报告。
  • VAS从均值38.2 ± 28.3改善至6个月时的70.7 ± 22.9,从40.1 ± 27.8改善至3年时的70.3 ± 23.1。
  • KCCQ从28.2 ± 23.9改善至6个月时的64.3 ± 23.2,从29.8 ± 23.7改善至3年时的63.0 ± 23.7。
  • 术前变量(包括基线VAS)对HRQOL的效应量较小,而术后不良事件有较大的负向效应量。
  • 近期卒中、呼吸衰竭和肾功能不全对6个月HRQOL的负向影响最大;近期肾功能不全、呼吸衰竭和感染对3年HRQOL的负向影响最大。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We sought to quantify the impact of pre- and postoperative variables on health-related quality of life (HRQOL) after left ventricular assist device (LVAD) implantation. METHODS: Primary durable LVAD implants between 2012 and 2019 in the Interagency Registry for Mechanically Assisted Circulatory Support were identified. Multivariable modeling using general linear models assessed the impact of baseline characteristics and postimplant adverse events (AEs) on HRQOL as assessed by the EQ-5D visual analog scale (VAS) and the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ) at 6 months and 3 years. RESULTS: Of 22,230 patients, 9,888 had VAS and 10,552 had KCCQ reported at 6 months, and 2,170 patients had VAS and 2,355 had KCCQ reported at 3 years postimplant. VAS improved from a mean of 38.2 ± 28.3 to 70.7 ± 22.9 at 6 months and from 40.1 ± 27.8 to 70.3 ± 23.1 at 3 years. KCCQ improved from 28.2 ± 23.9 to 64.3 ± 23.2 at 6 months and from 29.8 ± 23.7 to 63.0 ± 23.7 at 3 years. Preimplant variables, including baseline VAS, had small effect sizes on HRQOL while postimplant AEs had large negative effect sizes. Recent stroke, respiratory failure, and renal dysfunction had the largest negative effect on HRQOL at 6 months, while recent renal dysfunction, respiratory failure, and infection had the largest negative effect at 3 years. CONCLUSIONS: AEs following LVAD implantation have large negative effects on HRQOL in early and late follow-up. Understanding the impact of AEs on HRQOL may assist shared decision-making regarding LVAD eligibility. Continued efforts to reduce post-LVAD AEs are warranted to improve HRQOL in addition to survival.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Kilic A, Kwon JH, Grady KL, et al. Impact of adverse events on health-related quality of life after left ventricular assist device implantation: An STS INTERMACS analysis. J Heart Lung Transplant. 2023. PMID: 37040860. doi:10.1016/j.healun.2023.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。